Technological Innovation and Ecological Synergy in Biomaterials: China Innovative Medical Assets Roundtable Session 8

Key investment areas include: biomaterials, bio-manufacturing, AI + biology, and innovative composite medical devices. Led investments in projects such as Jiangsu Biosurf Biotech Co.,LTD (百赛飞), Morning Star Pharma (晨辰医药), Corliber (力文所), Betterfly (巴特弗莱), and Mountain-Sea Medical (山海医疗), and participated in the investment of dozens of enterprises.

Ph.D. in Engineering, a high-level talent of Jiangsu Province's "333 Project," Industrial Professor of Jiangsu Province, leading scientific and technological talent in Suzhou Industrial Park, and Vice Chairman of the Biological Materials Surface Interface Engineering Branch of the Chinese Society for Biomaterials. Since 2011, he has been engaged in surface interface research on biomaterials at the College of Materials, Chemistry, and Chemical Engineering at Soochow University, publishing over 50 SCI papers in international journals. He has led or participated in more than ten national projects, including key R&D programs from the Ministry of Science and Technology, major international cooperation projects, key projects, and general projects of the National Natural Science Foundation of China. In 2017, as a core member of the founding team, he served as the R&D Director of Jiangsu Biosurf Biotech Co., LTD, and has been the General Manager since 2018. He has led the R&D team in applying for dozens of coating-related invention patents. In 2025, he will be responsible for undertaking the key core technology research project in Suzhou City and drafting multiple standards for medical functional coatings, filling the gap in relevant domestic standards.

Ph.D. in Polymer Materials from NUS, Singapore; Dual Bachelor's Degrees in Materials Science and Finance from Shanghai Jiao Tong University; Senior Engineer; High-level Overseas Talent under Shenzhen's Peacock Plan.

Ph.D. from the Chinese Academy of Sciences, Co-founder of Novaprint Therapeutics&CEO. Own10Years of experience in the medical device industry, having worked successively atGE, Thermo Fisher and other global500A strong company, has accumulated rich experience in regenerative medicine research and technology industrialization. "Scientist+"Entrepreneur" Dual Identity.

Academic Positions: Formerly served as Associate Researcher at Suzhou Academy of Xi'an Jiaotong University, Part-time Graduate Supervisor at the School of Pharmaceutical Science of Soochow University, Part-time Researcher at Suzhou Academy of the Institute of Biochemistry and Cell Biology of the Chinese Academy of Sciences, and Part-time Professor at the School of Health Science and Engineering of the University of Shanghai for Science and Technology, etc. Member of the Expert Group of the Second Medical Device Additive Manufacturing Technology Committee, Standing Committee Member of the Medical Engineering Transformation and Health Industry Integration Committee of the Chinese Research Hospital Association, and Committee Member of the 3D Printing Technology Branch of the China Medical Biotechnology Association.